The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases.
Standard
The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. / Augustin, Matthias; Radtke, Marc; Zschocke, Ina; Blome, Christine; Behechtnejad, Julia; Schäfer, Ines; Reusch, Michael; Mielke, Volker; Rustenbach, Stephan Jeff.
in: ARCH DERMATOL RES, Jahrgang 301(8), 2009, S. 561-571.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases.
AU - Augustin, Matthias
AU - Radtke, Marc
AU - Zschocke, Ina
AU - Blome, Christine
AU - Behechtnejad, Julia
AU - Schäfer, Ines
AU - Reusch, Michael
AU - Mielke, Volker
AU - Rustenbach, Stephan Jeff
PY - 2009
Y1 - 2009
N2 - Evaluation of therapeutic benefits from the patient's perspective is important in medical decision-making and reimbursement. This study aimed at developing and validating an instrument on patient-defined needs and benefits in dermatology. The questionnaire was developed according to international guidelines. The benefit assessment consists of two steps: before treatment, every patient defines his treatment needs according to a standardized list. After treatment, the patient rates the degree of benefits achieved. A "patient benefit index" (PBI) is calculated by averaging the preference-weighed results of all items. The PBI questionnaire was validated in a sample of 500 patients with ten skin diseases and in a treatment study on 906 patients with acne. The patients defined a broad spectrum of needs and treatment benefits, indicating disease-specific patterns. The PBI showed good feasibility, reliability (Cronbach's alpha >0.91) and construct validity, high responsiveness, and discrimination between subgroups. The PBI permits valid evaluation of patient-relevant benefits in dermatological treatment.
AB - Evaluation of therapeutic benefits from the patient's perspective is important in medical decision-making and reimbursement. This study aimed at developing and validating an instrument on patient-defined needs and benefits in dermatology. The questionnaire was developed according to international guidelines. The benefit assessment consists of two steps: before treatment, every patient defines his treatment needs according to a standardized list. After treatment, the patient rates the degree of benefits achieved. A "patient benefit index" (PBI) is calculated by averaging the preference-weighed results of all items. The PBI questionnaire was validated in a sample of 500 patients with ten skin diseases and in a treatment study on 906 patients with acne. The patients defined a broad spectrum of needs and treatment benefits, indicating disease-specific patterns. The PBI showed good feasibility, reliability (Cronbach's alpha >0.91) and construct validity, high responsiveness, and discrimination between subgroups. The PBI permits valid evaluation of patient-relevant benefits in dermatological treatment.
M3 - SCORING: Zeitschriftenaufsatz
VL - 301(8)
SP - 561
EP - 571
JO - ARCH DERMATOL RES
JF - ARCH DERMATOL RES
SN - 0340-3696
ER -